UPDATED May 23, 2024
Annually loss-making mid-caps and large-caps with sound financial health.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
IVZ | US$15.46 | -3.9% | 5.2% | US$7.1b | US$16.70 | PS1.2x | E32.1% | 5.3% | Diversified Financials | ||
TFC | US$38.24 | -4.8% | 25.3% | US$52.0b | US$43.29 | PB1x | E70.6% | 5.4% | Banks | ||
BANC | US$13.77 | -2.3% | n/a | US$2.4b | US$16.84 | PB0.8x | E140.8% | 2.9% | Banks | ||
ACAD | US$15.54 | 4.6% | -36.4% | US$2.6b | US$27.16 | PS3.2x | E40.8% | n/a | Pharmaceuticals & Biotech | ||
FLNC | US$20.21 | 10.7% | -9.0% | US$3.6b | US$29.36 | PS1.2x | E100.8% | n/a | Capital Goods | ||
SMAR | US$40.73 | -2.9% | -11.7% | US$5.7b | US$49.26 | PS5.9x | E51.0% | n/a | Software | ||
INSP | US$154.82 | -2.6% | -47.8% | US$4.8b | US$250.73 | PS7x | E52.9% | n/a | Healthcare | ||
TEAM | US$174.18 | -4.4% | 9.6% | US$45.5b | US$240.61 | PS10.9x | E41.3% | n/a | Software | ||
PTVE | US$12.67 | -5.8% | 70.3% | US$2.3b | US$16.36 | PB1.7x | E69.8% | 3.2% | Materials | ||
IPL | AU$3.05 | 4.1% | 0.7% | AU$5.9b | AU$3.21 | PS1.1x | E48.0% | 4.9% | Materials | ||
SYM | US$41.48 | -10.1% | 17.4% | US$25.0b | US$56.64 | PS2.8x | E128.1% | n/a | Capital Goods | ||
FIVN | US$50.51 | -6.2% | -10.1% | US$3.9b | US$83.36 | PS4x | E61.9% | n/a | Software | ||
STJ | UK£4.88 | 2.2% | -56.1% | UK£2.7b | UK£7.07 | PB2.7x | E39.6% | 4.9% | Diversified Financials | ||
CRDO | US$19.10 | 0% | 59.4% | US$3.2b | US$26.42 | PS19x | E123.6% | n/a | Semiconductors | ||
AXSM | US$74.18 | -4.1% | 8.9% | US$3.6b | US$123.56 | PS14x | E65.1% | n/a | Pharmaceuticals & Biotech | ||
SPB | US$92.61 | -0.8% | 25.1% | US$2.7b | US$104.25 | PB1.2x | E35.6% | 1.8% | Household | ||
GLBE | US$29.45 | 3.7% | -9.3% | US$5.1b | US$43.42 | PS8.2x | E99.6% | n/a | Retail | ||
MHK | US$115.76 | -4.2% | 22.4% | US$7.5b | US$128.21 | PB1x | E48.0% | n/a | Consumer Durables | ||
DOW | AU$4.83 | 2.8% | 37.2% | AU$3.2b | AU$4.88 | PB1.5x | E52.3% | 2.9% | Commercial Services | ||
PATH | US$19.04 | -5.7% | 31.2% | US$11.2b | US$27.89 | PS8.3x | E58.3% | n/a | Software | ||
BGNE | US$156.17 | -8.7% | -31.4% | US$17.6b | US$267.01 | PS5.9x | E60.6% | n/a | Pharmaceuticals & Biotech | ||
ITCI | US$66.37 | -0.2% | 10.3% | US$7.1b | US$90.60 | PS13.6x | E60.5% | n/a | Pharmaceuticals & Biotech | ||
GDRX | US$7.24 | -10.2% | 38.2% | US$2.7b | US$9.40 | PS3.6x | E43.0% | n/a | Healthcare | ||
AMED | US$96.20 | 1.3% | 25.3% | US$3.2b | US$97.78 | PS1.4x | E68.4% | n/a | Healthcare |